chlorpromazine has been researched along with cromolyn sodium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Drasar, BS; Giugliano, LG | 1 |
| Church, MK; Young, KD | 2 |
4 other study(ies) available for chlorpromazine and cromolyn sodium
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The influence of drugs on the response of a cell culture preparation to bacterial toxins.
Topics: Adenylyl Cyclases; Animals; Bacterial Proteins; Bacterial Toxins; Calcium; Calmodulin; Cells, Cultured; Chlorocebus aethiops; Chlorpromazine; Cholera Toxin; Cromolyn Sodium; Cytotoxins; Drug Synergism; Enterotoxins; Escherichia coli Proteins; Guanylate Cyclase; Indomethacin; Kidney; Lanthanum; Nucleotides, Cyclic; Prostaglandins; Shiga Toxin 1 | 1984 |
Passive anaphylaxis in human lung fragments as a model for testing anti-allergic drugs: its variability and constraints.
Topics: Albuterol; Chlorpromazine; Cromolyn Sodium; Histamine Release; Humans; Hypersensitivity; Lung; Models, Biological; Passive Cutaneous Anaphylaxis; Phenanthrolines; Pollen | 1983 |
The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine.
Topics: Albuterol; Calcium; Chlorpromazine; Cromolyn Sodium; Drug Tolerance; Histamine Release; Humans; In Vitro Techniques; Lung; Propranolol; Time Factors | 1983 |